Saar M - Search Results

1

²²⁵Ac-PSMA-617/¹⁷⁷Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience.

Khreish F, Ebert N, Ries M, Maus S, Rosar F, Bohnenberger H, Stemler T, Saar M, Bartholomä M, Ezziddin S. Khreish F, et al. Among authors: saar m. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):721-728. doi: 10.1007/s00259-019-04612-0. Epub 2019 Nov 22. Eur J Nucl Med Mol Imaging. 2020. PMID: 31758224

2

Robotic salvage lymph node dissection for nodal-only recurrences after radical prostatectomy: Perioperative and early oncological outcomes.

Linxweiler J, Saar M, Al-Kailani Z, Janssen M, Ezziddin S, Stöckle M, Siemer S, Ohlmann CH. Linxweiler J, et al. Among authors: saar m. Surg Oncol. 2018 Jun;27(2):138-145. doi: 10.1016/j.suronc.2018.02.010. Epub 2018 Feb 24. Surg Oncol. 2018. PMID: 29937163

3

Response and outcome of liver metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) undergoing ¹⁷⁷Lu-PSMA-617 radioligand therapy.

Khreish F, Kochems N, Rosar F, Sabet A, Ries M, Maus S, Saar M, Bartholomä M, Ezziddin S. Khreish F, et al. Among authors: saar m. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):103-112. doi: 10.1007/s00259-020-04828-5. Epub 2020 May 6. Eur J Nucl Med Mol Imaging. 2021. PMID: 32378019

4

Can local treatment prolong the sensitivity of metastatic prostate cancer to androgen deprivation or even prevent castration resistance?

Niklas C, Saar M, Nini A, Linxweiler J, Siemer S, Junker K, Stoeckle M. Niklas C, et al. Among authors: saar m. World J Urol. 2021 Sep;39(9):3231-3237. doi: 10.1007/s00345-020-03568-3. Epub 2021 Jan 27. World J Urol. 2021. PMID: 33502558 Free PMC article.

5

Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management.

Linxweiler J, Sprenk J, Cascetta K, Pryalukhin A, Hölters S, Zeuschner P, Nini A, Al-Kailani Z, Ezziddin S, Bohle RM, Fries P, Ohlmann CH, Heinzelbecker J, Siemer S, Stöckle M, Junker K, Saar M. Linxweiler J, et al. Among authors: saar m. J Urol. 2021 Jul;206(1):88-96. doi: 10.1097/JU.0000000000001697. Epub 2021 Feb 22. J Urol. 2021. PMID: 33617326

6

Quality of Preoperative Biopsy Is a Risk Factor for Positive Surgical Margins in Organ-Confined Prostate Cancer Treated with Nerve-Sparing Robot-Assisted Radical Prostatectomy.

Bütow Z, Schunk S, Janssen M, Gräber S, Saar M, Kamradt J, Siemer S, Stöckle M, Ohlmann CH. Bütow Z, et al. Among authors: saar m. Urol Int. 2015;95(4):465-71. doi: 10.1159/000440666. Epub 2015 Nov 18. Urol Int. 2015. PMID: 26575991

7

Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up.

Hajili T, Ohlmann CH, Linxweiler J, Niklas C, Janssen M, Siemer S, Stoeckle M, Saar M. Hajili T, et al. Among authors: saar m. BJU Int. 2019 Jan;123(1):58-64. doi: 10.1111/bju.14393. Epub 2018 Jun 7. BJU Int. 2019. PMID: 29772100

8

Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer.

Linxweiler J, Hammer M, Muhs S, Kohn M, Pryalukhin A, Veith C, Bohle RM, Stöckle M, Junker K, Saar M. Linxweiler J, et al. Among authors: saar m. J Cancer Res Clin Oncol. 2019 Mar;145(3):551-559. doi: 10.1007/s00432-018-2803-5. Epub 2018 Nov 24. J Cancer Res Clin Oncol. 2019. PMID: 30474758

9

MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.

Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M, Müller A, Spahn M, Seitz AK, Frank T, Marouf H, Büchel G, Eckstein M, Kübler H, Eilers M, Saar M, Junker K, Röhrig F, Kneitz B, Rosenfeldt MT, Schulze A. Kalogirou C, et al. Among authors: saar m. Nat Commun. 2021 Aug 20;12(1):5066. doi: 10.1038/s41467-021-25325-9. Nat Commun. 2021. PMID: 34417456 Free PMC article.

10

Primary Tumor Resection Decelerates Disease Progression in an Orthotopic Mouse Model of Metastatic Prostate Cancer.

Linxweiler J, Hajili T, Zeuschner P, Menger MD, Stöckle M, Junker K, Saar M. Linxweiler J, et al. Among authors: saar m. Cancers (Basel). 2022 Jan 31;14(3):737. doi: 10.3390/cancers14030737. Cancers (Basel). 2022. PMID: 35159004 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page